|
| | 
|
 | |
        
|  |
 
|
| PS: The quotes after 2018-12-04 are still temporary and may have for that reason the Open values wrong until furter updates...
Change to Merck & Company Static Chart |
 Merck & Company - [Ticker: MRK] |     | | Last Trade | 79.37 | Last Trade Time | 2018-12-04 - 00:00:00 | | Variation | +0.15 (+1.00%) | Open | 79.30 | | High | 80.19 | Low | 79.18 | | Volume | 4,330,639 | Average Volume (3m) | 0 | | Yield | | Bid / Ask | 55.43 x 900 - 55.44 x 2,100 | | Former Close | 79.22 | 52 Week Range | [0.00 - 0.00] | | PER | 0.00% | EPS | 0.00 | | Ex-Dividend Date | | Dividend Payment | | | Market Capitalization | 0 | 1 Year Price-Target | 0.00 | | Note: The data may have some minutes of delay. |
|
News about Merck & Company [MRK]: (ordered by relevance)
| - Merck's Covid pill secures narrow backing from US regulatory panel Financial Times
- Merck says its COVID-19 drug should be effective against any variant Reuters
- Merck?s COVID-19 pill may soon be here. How well will it work? Science News
- Merck?s Covid Treatment Pill Wins Blessing of F.D.A. Panel The New York Times
- What's Next For Merck Stock After FDA Advisors Back Its Covid-19 Pill? Forbes
- Is A Rise Imminent For Merck Stock After An 8% Fall In A Month? Forbes
- Why Merck Stock Is Slipping Today The Motley Fool
- Merck stock dives after Citi downgrades on 'high probability' that HIV treatment will be abandoned MarketWatch
- Merck Stock Is A Strong Buy On The Drop (NYSE:MRK) Seeking Alpha
Why molnupiravir could still work for Merck Vantage
South Africa in Talks With Pfizer, Merck for Covid Pills Bloomberg
UK First Country to Approve Merck's COVID-19 Pill Pharmaceutical Executive
Merck says its Covid antiviral treatment less effective than first thought Financial Times
Stocks making the biggest moves midday: Twitter, Moderna, Merck, Tesla and more CNBC
U.K. Set to Deploy Merck's Covid Pill in 10000-Person Study Bloomberg
EU recommends Merck COVID-19 pill for adults at risk of severe illness Reuters
Belgium in talks to buy 10000 doses of Merck's COVID-19 pill, health minister says Reuters
Merck & Co. Inc. stock underperforms Thursday when compared to competitors MarketWatch
Merck Closes Deal for Acceleron Pharma, Biggest Biotech Merger of the Year Barron's
Buffett's Berkshire exited Merck investment just before COVID pill boost, further trimmed AbbVie and BMS holdings FiercePharma
Merck (MRK) Vaxneuvance sBLA for Pediatrics Gets Priority Review Entrepreneur
Pfizer boosts Paxlovid manufacturing capacity as Merck's rival COVID pill hits surprise efficacy setback FiercePharma
Lab worker finds vials labeled ?smallpox? at Merck facility Fox 56
Pfizer, like Merck, inks deal to license COVID-19 pill and boost global supply FiercePharma
Merck's New Covid Drug Molnupiravir Gets FDA Approval In Time for Omicron Bloomberg
Deutsche Bank : delivers intelligence & automation for Merck India's cross-border cash flows marketscreener.com
Merck, AstraZeneca's sNDA for breast cancer treatment granted priority review by the FDA MarketWatch
Merck Applies for Covid Pill Approval in Japan, Nikkei Reports marketscreener.com
Merck's Covid Pill Partner in India Sees a Short-Lived Boom Bloomberg
Merck will support Saudi Arabia effort to build biologics manufacturing operations FiercePharma
What?s Next For Merck Stock After An Upbeat Q3? Forbes
Covid News: U.S. to Tighten Testing for Travelers Amid Omicron Worries The New York Times
Yet another Acceleron investor challenges Merck's $11.5B acquisition offer: Bloomberg FiercePharma
Merck to Present at the 4th Annual Evercore ISI HealthCONx Conference Business Wire
Merck signs strategic agreement with GI Innovation to develop biomedicine Korea Biomedical Review
Merck HIV combo sees approval chances soar to 99%: regulatory roundup Clinical Trials Arena
AHA 2021 ? Merck?s oral cholesterol lowerer could heap more misery on Esperion Vantage
Merck expects Covid pill to reach rich and poor countries simultaneously FRANCE 24
Merck Highlights Novel Mechanisms with the Potential to Transform Standards of Care in Several Cancers, MS, and Lupus Business Wire
FDA approves Merck's Keytruda as first immunotherapy for early kidney cancer BioPharma Dive
A worrisome safety signal slows Merck's HIV ambitions BioPharma Dive
Better Buy: Bristol Myers Squibb vs. Merck Nasdaq
Merck, Box Rise Premarket; Salesforce Falls By Investing.com Investing.com
Merck and Ridgeback to Present Phase 3 Data for Molnupiravir, an Investigational Oral COVID-19 Antiviral Medicine, at American Society of Tropical Medicine and Hygiene (ASTMH) 2021 Annual Meeting Business Wire
Italy to acquire 50000 courses for each of Merck, Pfizer COVID-19 antiviral drugs Reuters
German, Austrian authorities approve Merck acquisition of Acceleron Pharmaceutical Business Review
Salesforce, Merck, Cathie Wood, Twitter; Stocks Rebound - 5 Things You Must Know TheStreet
Better COVID Stock: Merck vs. Pfizer Motley Fool
UPDATED: Biogen pulls PRIME designation for aducanumab in Europe; Merck closes merger with Acceleron Endpoints News
Indonesia reviewing Merck COVID-19 pill, up to 1 mln doses targeted Reuters
Here's Why Merck Stock Vaulted Higher in October The Motley Fool
Merck Says It's Working With China to Bring In Its Covid Pill Bloomberg
Merck KGaA's Schistosomiasis Drug Shows Positive Results in Phase-3 Children Trial MarketWatch
Countries rush to buy Merck and Pfizer's experimental COVID-19 pills Rappler
As Merck and Pfizer predict incoming billions from their COVID drugs, Roche culls pandemic ties with Atea FierceBiotech
Novartis May Have a Suitor for Sandoz; Merck Closes Acceleron Deal BioSpace
Months after a Merck spinout, Organon continues its string of deals with a $954M buyout package Endpoints News
Merck Receives Another Boost for Its Top-Selling Drug Motley Fool
Merck's Plan B Percolates After Pfizer Announces Dominance Seeking Alpha
Merck stock's biggest selloff in nearly 17 years is cutting close to 60 points off the Dow's price MarketWatch
Merck signs pact to broaden generic manufacturing of COVID-19 pill Reuters
Merck potential animal health spin could be next after J&J split up Seeking Alpha
Greek American Physician Helped Develop Merck Corona Pill Greek Reporter
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data Yahoo Finance
Merck COVID-19 pill sparks calls for access for lower income countries Reuters
A new boss, a new path forward and new challenges for N.J. pharma giant nj.com
The U.K. approves Merck's COVID-19 antiviral pill, calling it a world first Minnesota Public Radio News
How Will Merck's Stock Forecast Be Impacted By U.K.'s COVID Pill Authorization? Seeking Alpha
UK authorizes Merck's coronavirus treatment, the first pill shown to be effective at treating COVID-19 ABC News
Merck-Pfizer immunotherapy gets expanded indication for urothelial cancer Korea Biomedical Review
UK approves Merck's COVID pill in world first Yahoo Singapore News
Merck pill seen as 'huge advance,' raises hope of preventing COVID-19 deaths Reuters
COVID-19: Treatments approved in Canada CTV News
Merck to collaborate with Ontada on data-driven cancer insights OutSourcing-Pharma.com
Merck to buy Acceleron Pharma for $11.5bn Financial Times
Merck on deals hunt as patent cliff looms for top cancer drug Financial Times
Merck, Evidation join forces on Alzheimer's data solutions OutSourcing-Pharma.com
Pfizer, Merck launch new trials of oral COVID-19 drugs Reuters
Merck wants Americans to pay $712 for a Covid drug that taxpayers helped develop The Guardian
What?s Next For Merck Stock After A 5% Fall In A Week? Forbes
Can Merck's new boss maintain the drugmaker's winning streak? The Economist
Merck's Gesture to Save Humanity From COVID-19 Fair Observer
U.S. signs $1.2 bln deal for 1.7 mln courses of Merck's experimental COVID-19 drug Reuters
Merck and Singapore sign deal on COVID-19 antiviral pill Reuters
UK creates deal for 480,000 doses of Merck COVID pill Open Access Government
Merck KGaA, GSK end partnership on former cancer drug hopeful Reuters
A bear and a bull debate the move in health care after Merck?s Covid pill breakthrough CNBC
Merck develops new technology to address solubility and speed to market challenges of ADCs BioPharma-Reporter.com
Merck: COVID-related work helped Q1 growth - BioProcess Insider BioProcess Insider
EU Panel May Start Accelerated Review of Merck's Covid Pill Bloomberg
Merck drug less effective against moderate COVID -India regulatory source Reuters
Merck strikes deal for global access to Covid drug FRANCE 24
Merck taps Xeris for ready-to-use versions of antibody products FiercePharma
Merck to continue tests of Covid pill, but stop trial in hospitalized patients STAT
Merck Sales Beat Estimates, But the Stock Fell. Here?s 1 Reason to Be Bullish. Barron's
Merck, Codexis extend supply deal for key API in Januvia, Janumet FiercePharma
Gilead, Merck and others slapped with 'pay-for-delay' lawsuits over lucrative HIV and cholesterol meds FiercePharma
Merck KGaA says lab supplies business can grow by up to 10% per year Reuters
Merck Announces Appointment of Head of China & International for Healthcare Business Wire
Merck rolls out new lipid technology ahead of schedule BioPharma-Reporter.com
Merck KGaA's new CEO shakes up U.S. leadership to spark sales of promising drugs FiercePharma
WHO says seeks more data from Merck on COVID anti-viral, from Bharat on vaccine Reuters
Merck Announces Completion of Organon & Co. Spinoff Business Wire
As Organon charts post-spinoff future, Merck's $9B cash infusion could fund big M&A score FiercePharma
Merck's Welireg scores FDA nod in cancers spurred by rare disease?and its label is broader than expected FiercePharma
Merck begins late-stage trial of experimental COVID-19 drug Reuters
Merck spin-off Organon sees share price jump at Q2 results PMLiVE
| For more news about Merck & Company click here:
Merck & Company News |
|
Website Width:
Background image: |
|  | |
|
|
